CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 30,000 shares at $17.45 ($523,500)
- 4 Open-market buy Director bought 18,477 shares at an average $16.67 ($307,928)
- 4 Exercise or conversion Director acquired 1,000 shares (option exercise)
- 4 Shares withheld for taxes President and CEO gave up 57,268 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 9,284 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Director gave up 7,077 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 5,139 shares (to pay taxes)
- 4 Open-market buy Director bought 88,841 shares at an average $25.81 ($2,292,823)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
Page 4 of 30 · 591 filings